Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome.

    Tesauro M, Schinzari F, Rovella V, Melina D, Mores N, Barini A, Mettimano M, Lauro D, Iantorno M, Quon MJ, Cardillo C.

    Diabetes Care. 2008 Jul;31(7):1439-41. Epub 2008 Apr 4.PMID: 18390795 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.

    Cardillo C, Schinzari F, Mores N, Mettimano M, Melina D, Zoli A, Ferraccioli G.

    Clin Pharmacol Ther. 2006 Sep;80(3):275-81.PMID: 16952494 [PubMed - indexed for MEDLINE]Related articles

    3.

    Ghrelin improves endothelial function in patients with metabolic syndrome.

    Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D, Cardillo C.

    Circulation. 2005 Nov 8;112(19):2986-92. Epub 2005 Oct 31.PMID: 16260640 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.

    Schinzari F, Armuzzi A, De Pascalis B, Mores N, Tesauro M, Melina D, Cardillo C.

    Clin Pharmacol Ther. 2008 Jan;83(1):70-6. Epub 2007 May 16.PMID: 17507924 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome.

    Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C.

    Circ Res. 2006 Jul 7;99(1):69-77. Epub 2006 Jun 1.PMID: 16741160 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.

    Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB.

    Circulation. 2004 Apr 13;109(14):1718-23. Epub 2004 Mar 22.PMID: 15037536 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans.

    Rask-Madsen C, Domínguez H, Ihlemann N, Hermann T, Køber L, Torp-Pedersen C.

    Circulation. 2003 Oct 14;108(15):1815-21. Epub 2003 Oct 6.PMID: 14530204 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

    Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD.

    J Clin Invest. 1996 Jun 1;97(11):2601-10.PMID: 8647954 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.

    Fichtlscherer S, Rössig L, Breuer S, Vasa M, Dimmeler S, Zeiher AM.

    Circulation. 2001 Dec 18;104(25):3023-5.PMID: 11748093 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines.

    Holm T, Aukrust P, Andreassen AK, Ueland T, Brosstad F, Frøland SS, Simonsen S, Gullestad L.

    Clin Transplant. 2000 Jun;14(3):218-25.PMID: 10831080 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.

    Tack CJ, Ong MK, Lutterman JA, Smits P.

    Diabetologia. 1998 May;41(5):569-76.PMID: 9628275 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.

    Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, Tambascia M, Bouskela E.

    Clinics (Sao Paulo). 2006 Oct;61(5):433-40.PMID: 17072441 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension.

    Cardillo C, Campia U, Kilcoyne CM, Bryant MB, Panza JA.

    Circulation. 2002 Jan 29;105(4):452-6.PMID: 11815427 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C.

    Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL.

    Diabetes. 2001 Jan;50(1):159-65.PMID: 11147782 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release.

    Patel JN, Jager A, Schalkwijk C, Corder R, Douthwaite JA, Yudkin JS, Coppack SW, Stehouwer CD.

    Clin Sci (Lond). 2002 Oct;103(4):409-15.PMID: 12241541 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.

    de Aguiar LG, Bahia LR, Villela N, Laflor C, Sicuro F, Wiernsperger N, Bottino D, Bouskela E.

    Diabetes Care. 2006 May;29(5):1083-9.PMID: 16644641 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.

    Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Béchir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Lüscher TF, Gay S, Ruschitzka F.

    Circulation. 2002 Oct 22;106(17):2184-7.PMID: 12390945 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

    Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Saccà L, Ferrannini E.

    Diabetes. 2006 Apr;55(4):1133-40.PMID: 16567539 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.

    Chia S, Qadan M, Newton R, Ludlam CA, Fox KA, Newby DE.

    Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):695-701. Epub 2003 Mar 6.PMID: 12692009 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Chronic hyperinsulinemia enhances adrenergic vasoconstriction and decreases calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.

    Takatori S, Zamami Y, Mio M, Kurosaki Y, Kawasaki H.

    Hypertens Res. 2006 May;29(5):361-8.PMID: 16832157 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data